影像学定义的肌肉减少症影响头颈癌生存:一项荟萃分析
结果显示,肌肉减少症患者OS显著较差(HR=1.98;95%CI:1.64-2.39;P<.00001),总体及亚组分析均未检测到异质性。结论认为影像学肌肉减少症是头颈癌患者OS的不良预测因素,早期识别可能有助于指导营养及辅助支持以改善治疗结局。
要点
- 影像学肌肉减少症与头颈癌患者总生存期显著较差相关(HR=1.98)。
- 该关联在总体及亚组分析中均未检测到异质性。
- 早期识别肌肉减少症可能有助于指导营养与辅助支持。
核心结论
- 影像学定义的肌肉减少症是头颈癌患者总生存期的不良预测因素。
研究设计与样本
- 检索PubMed、Embase和Scopus(2019年7月12日),仅限英文全文,无发表日期限制。
- 采用随机效应DerSimonian and Laird法进行荟萃分析,使用Quality In Prognosis Studies工具评估研究质量。
主要发现
- 肌肉减少症头颈癌患者的总生存期显著较差(HR=1.98;95%CI:1.64-2.39;P<.00001)。
- 总体及亚组分析均未检测到异质性。
临床怎么用
- 早期检测头颈癌患者的肌肉减少症可能有助于指导营养及辅助支持,以改善治疗结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether radiologically defined sarcopenia at the C3 or L3 level as measured by computed tomography or magnetic resonance imaging is prognostic of overall survival (OS) in head and neck cancers (HNCs). METHODS: Literature searches of PubMed, Embase, and Scopus were conducted on July 12, 2019, to include articles written in the English language with no constraints on publication date. To be included in the analysis, articles had to report the prognostic impact of skeletal muscle mass measured radiologically at the C3 or L3 vertebral level in HNC patients; hazard ratios (HRs) for OS; 95% confidence intervals (CIs); be from a clinical trial, cohort, or case-control study; and have English full-text availability. Articles were reviewed in consensus by two reviewers, with disagreements reviewed by a third reviewer. Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analysis Of Observational Studies in Epidemiology Checklist guidelines were used for reporting. Study quality assessment was performed using Quality In Prognosis Studies tool. The random-effects DerSimonian and Laird method was used for meta-analysis. RESULTS: Ten articles, nine retrospective and one prospective, were included in this meta-analysis (n = 2,181 patients). Significant differences were found in OS for HNC patients with sarcopenia (HR = 1.98; 95% CI: 1.64-2.39; P < .00001). No heterogeneity was detected in either the overall or subgroup analyses. CONCLUSIONS: Radiologically defined sarcopenia is a negative predictor of OS in patients with HNC. Early detection of sarcopenia in cancer patients may help guide nutritional and adjuvant support to improve treatment outcomes. LEVEL OF EVIDENCE: NA Laryngoscope, 131:333-341, 2021.
引用
- Wong A, Zhu D, Kraus D, et al. Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope. 2020. PMID: 32220072. doi:10.1002/lary.28616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。